268 related articles for article (PubMed ID: 19461506)
1. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.
Skálová A; Sima R; Vanecek T; Muller S; Korabecna M; Nemcova J; Elmberger G; Leivo I; Passador-Santos F; Walter J; Rousarova M; Jedlickova K; Curik R; Geierova M; Michal M
Am J Surg Pathol; 2009 Aug; 33(8):1137-45. PubMed ID: 19461506
[TBL] [Abstract][Full Text] [Related]
2. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature.
Seethala RR; Hunt JL; Baloch ZW; Livolsi VA; Leon Barnes E
Am J Surg Pathol; 2007 Nov; 31(11):1683-94. PubMed ID: 18059225
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE
Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
[TBL] [Abstract][Full Text] [Related]
5. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
7. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study.
Triantafillidou K; Iordanidis F; Psomaderis K; Kalimeras E
J Oral Maxillofac Surg; 2010 Oct; 68(10):2489-96. PubMed ID: 20678839
[TBL] [Abstract][Full Text] [Related]
8. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
[TBL] [Abstract][Full Text] [Related]
9. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
Cornolti G; Ungari M; Morassi ML; Facchetti F; Rossi E; Lombardi D; Nicolai P
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328
[TBL] [Abstract][Full Text] [Related]
11. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma.
Chiosea SI; Griffith C; Assaad A; Seethala RR
Am J Surg Pathol; 2012 Mar; 36(3):343-50. PubMed ID: 22301503
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and Immunophenotypic Characterization of 25 Cases of Acinic Cell Carcinoma with High-Grade Transformation.
Thompson LD; Aslam MN; Stall JN; Udager AM; Chiosea S; McHugh JB
Head Neck Pathol; 2016 Jun; 10(2):152-60. PubMed ID: 26245749
[TBL] [Abstract][Full Text] [Related]
13. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
14. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
[TBL] [Abstract][Full Text] [Related]
15. p53 and cyclinX D1 protein expression in carcinomas of the parotid gland.
Pignataro L; Capaccio P; Carboni N; Pruneri G; Ottaviani A; Buffa R; Broich G
Anticancer Res; 1998; 18(2B):1287-90. PubMed ID: 9615803
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus.
van Dekken H; Hop WC; Tilanus HW; Haringsma J; van der Valk H; Wink JC; Vissers KJ
Am J Clin Pathol; 2008 Nov; 130(5):745-53. PubMed ID: 18854267
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated acinic cell carcinoma of the parotid gland: a distinct rarely described entity.
Henley JD; Geary WA; Jackson CL; Wu CD; Gnepp DR
Hum Pathol; 1997 Jul; 28(7):869-73. PubMed ID: 9224759
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
19. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
20. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas.
Gugger M; Burckhardt E; Kappeler A; Hirsiger H; Laissue JA; Mazzucchelli L
J Pathol; 2002 Apr; 196(4):408-15. PubMed ID: 11920736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
